Investor Information

IR banner
Webcast ImageWebcast - Replay
Express Scripts Holding Co at Morgan Stanley Global Healthcare Conference
09/14/16 at 1:00 p.m. ET
Express Scripts Holding Co at Morgan Stanley Global Healthcare Conference
Wednesday, September 14, 2016 1:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Business Overview

Business Overview
At Express Scripts we believe in practicing pharmacy smarter. We put medicine within reach of tens of millions of people by aligning with our customers, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

Stock chart for: ESRX.O.  Currently trading at $71.34 with a 52 week high of $89.20 and a 52 week low of $65.55.
ESRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$71.34
Change (%) Stock is Up 0.31 (0.44%)
Volume4,028,976
Data as of 09/23/16 4:00 p.m. ET
Refresh quote
Recent Press Releases
Express Scripts Launches Inflammatory Conditions Care Value Program(SM), Making America's Costliest Medication Class More Affordable - 09/08/2016 - 7:01 a.m.
New Value-Based Model Aligns Drug Payments to Specific Medical Conditions and Refunds Payers for Early Discontinuation of Expensive Medications ST. LOUIS, Sept. 8, 2016 /PRNewswire/ -- Expre... 
Express Scripts Holding Company to Present at an Upcoming Conference - 09/01/2016 - 2:38 p.m.
ST. LOUIS, Sept. 1, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (the "Company" or "Express Scripts") announced today that it will present at the Morgan Stanley Global Healthcar... 
Express Scripts Launches Diabetes Care Value Program℠, Guaranteeing More Affordable, Higher-Quality Diabetes Care - 08/31/2016 - 12:02 a.m.
Plans Adopting Novel Approach Will Cut Anticipated 2017 Diabetes Drug Trend in Half ST. LOUIS, Aug. 31, 2016 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today announced the launch of its Diabe... 
Express Scripts Announces Final Results of Maximum Tender Offers - 07/28/2016 - 9:15 a.m.
ST. LOUIS, Mo., July 28, 2016 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) (the "Company" or "Express Scripts") today announced the final tender results for its previously announced ... 
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Express Scripts Holding Co posts new information to the site. Just enter your e-mail address and click Submit.
 

Tax Consequences of Express Scripts and Medco Merger

Investor Overview
Learn more about Express Scripts and find corporate and shareholder information.

Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print | E-mail Page E-mail Page | RSS Feeds RSS | E-mail Alerts Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet